Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEPHROPATHY AND/OR DIABETES MELLITUS, COMPRISING ENAVOGLIFLOZIN
Document Type and Number:
WIPO Patent Application WO/2024/076177
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition comprising enavogliflozin as an active ingredient for the prevention or treatment of diabetes and/or renal diseases in patients who have or are at risk of diabetes and/or renal diseases.
Inventors:
SONG HWA RANG (KR)
KIM YOUNG HEE (KR)
NAH JAE JIN (KR)
HUH WAN (KR)
CHO SEUNG AH (KR)
PARK MI HEE (KR)
LEE SI EUN (KR)
KIM SU YOUNG (KR)
CHO BO YOUNG (KR)
KIM YOUNG HEE (KR)
NAH JAE JIN (KR)
HUH WAN (KR)
CHO SEUNG AH (KR)
PARK MI HEE (KR)
LEE SI EUN (KR)
KIM SU YOUNG (KR)
CHO BO YOUNG (KR)
Application Number:
PCT/KR2023/015349
Publication Date:
April 11, 2024
Filing Date:
October 05, 2023
Export Citation:
Assignee:
DAEWOONG PHARMACEUTICAL CO LTD (KR)
International Classes:
A61K31/351; A61P3/10; A61P13/12
Domestic Patent References:
| WO2021207723A2 | 2021-10-14 |
Foreign References:
| KR20130137628A | 2013-12-17 | |||
| KR20150130177A | 2015-11-23 | |||
| KR20100055422A | 2010-05-26 | |||
| KR20100103874A | 2010-09-28 |
Attorney, Agent or Firm:
DANA PATENT LAW FIRM (KR)
Download PDF: